ENO1 and pulmonary hypertension: ENO1 encodes alpha-enolase, a glycolytic enzyme that catalyzes the conversion of 2-phosphoglycerate to phosphoenolpyruvate, which had been reported to mediate the malignant phenotypes of PASMCs in pulmonary hypertension, including hyperproliferation, apoptosis resistance, and metabolic conversion (15).